Wedbush Initiates STAAR Surgical Coverage with Neutral Recommendation, Analysts Predict 43.12% Upside in Average Price Target.

Wedbush initiates coverage of STAAR Surgical (STAA) with a Neutral recommendation. The average one-year price target is $25.82/share, representing a 43.12% increase from its latest closing price. The projected annual revenue is 584MM, a 153.38% increase, and the projected annual non-GAAP EPS is 3.77.